Stock of the Week – Merck & Co Inc (23.10.2025)
Since the beginning of the year, Merck & Company Inc. shares have lost value, despite the company’s fundamentals remaining strong and stable. Has the market overestimated the risks, or has a unique opportunity opened up for investors to buy undervalued assets in the pharmaceutical sector? It is worth emphasizing that pharmaceutical companies are often considered defensive, as investors tend to allocate capital to them during economic slowdowns, seeking safe havens. In this analysis, we will review the key market trends, financial results, and development strategy of Merck to assess whether this pharmaceutical giant deserves a higher valuation.
